Bridgefront Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,275
| Closed | -$722K | – | 616 |
|
|
2025
Q1 | $722K | Buy |
+5,275
| New | +$722K | 0.21% | 158 |
|
|
2024
Q4 | – | Sell |
-3,243
| Closed | -$629K | – | 587 |
|
|
2024
Q3 | $629K | Buy |
+3,243
| New | +$629K | 0.24% | 132 |
|
|
2023
Q3 | – | Sell |
-975
| Closed | -$278K | – | 403 |
|
|
2023
Q2 | $278K | Buy |
+975
| New | +$278K | 0.15% | 276 |
|
|
2023
Q1 | – | Sell |
-1,445
| Closed | -$400K | – | 424 |
|
|
2022
Q4 | $400K | Sell |
1,445
-144
| -9% | -$39.9K | 0.28% | 140 |
|
|
2022
Q3 | $424K | Buy |
+1,589
| New | +$424K | 0.43% | 62 |
|